Alerts will be sent to your verified email
Verify Email
SHAMROIN
|
Shamrock Indl. Co
|
Kobo Biotech
|
Ganga Pharma.
|
|
|---|---|---|---|
|
Operational Metrics
|
|||
|
Financials
|
|||
|
5 yr Average ROE
|
-8.9 % | -1.77 % | 1.2 % |
|
5yr average Equity Multiplier
|
1.02 | 4.06 | 1.4 |
|
5yr Average Asset Turnover Ratio
|
0.0 | 0.54 | 0.33 |
|
5yr Avg Net Profit Margin
|
0.0 | -3.79 % | 2.35 % |
|
Price to Book
|
4.24 | 0.0 | 0.0 |
|
P/E
|
0.0 | 0.0 | 139.02 |
|
5yr Avg Cash Conversion Cycle
|
0.0 | 0.0 | 183.46 Days |
|
Inventory Days
|
0.0 | 89.28 Days | 158.14 Days |
|
Days Receivable
|
0.0 | 0.0 | 120.91 Days |
|
Days Payable
|
68.55 Days | 147.48 Days | 141.14 Days |
|
5yr Average Interest Coverage Ratio
|
0.0 | 0.99 | 1.42 |
|
5yr Avg ROCE
|
-8.89 % | 11.79 % | 4.7 % |
|
5yr Avg Operating Profit Margin
|
0.0 | 8.83 % | 3.58 % |
|
5 yr average Debt to Equity
|
0.0 | 1.62 | 0.3 |
|
5yr CAGR Net Profit
|
-28.89 % | n/a | -23.43 % |
|
5yr Average Return on Assets
|
-8.72 % | -0.89 % | 0.85 % |
|
Shareholdings
|
|||
|
Promoter Holding
|
42.98 % | 44.95 % | 56.02 % |
|
Share Pledged by Promoters
|
0.0 | 0.0 | 0.0 |
|
Change in Promoter Holding (3 Yrs)
|
0.0 | 0.0 | -10.69 % |
|
Change in Mutual Fund Holding (3 Yrs)
|
0.0 | 0.0 | 0.0 |
|
Shamrock Indl. Co
|
Kobo Biotech
|
Ganga Pharma.
|
|
|---|---|---|---|
|
Product Wise Break-Up
|
Product Wise Break-Up
|
Product Wise Break-Up
|
Product Wise Break-Up
|